Advancing Cognitive Health Through Scientific Synergy

 

Rigorous science, and collaboration in developing novel small-molecule therapies that address the root causes of Alzheimer’s disease

What We Do

Cognitive Synergy Corporation develops novel small-molecule therapies for Alzheimer’s disease and related neurodegenerative disorders. Our lead candidate restores synaptic health while reducing amyloid and tau pathology, aiming to deliver the first truly disease-modifying treatment for patients and families worldwide.

Who We Are

Cognitive Synergy Corporation is a biotechnology company dedicated to transforming the treatment of Alzheimer’s disease. We bring together innovative science, translational biomarkers, and collaborative partnerships to develop novel small-molecule therapies that address the root drivers of neurodegeneration. Guided by both scientific rigor and patient need, we are committed to delivering therapies that not only slow disease progression but also restore cognitive health and quality of life.

For years, Cognitive Synergy Corporation's research program has achieved advancements that were once thought impossible. As we bring new products into clinical development, our goal remains the same – to discover, develop and commercialize therapeutics that transform care for people around the world.